Recombinant Canine α interferon for injection 2 million IU Uzzhx0104593

Features

1. Pharmacological action

• Recombinant canine interferon A is a new generation of highly active large interferon products. Has extensive antiviral effects: inhibits intracellular virus replication and proliferation, effectively inhibiting both natural and mutated viruses. It has an immune-enhancing effect, promotes the function of macrophages, lymphocytes, and NK cells in the body, and can eliminate extracellular viruses. Therefore, it has dual antiviral effects both intracellular and extracellular

2. Indications

•  Major viral diseases. Including major fever, major and minor cases, major coronavirus, major H3NB influenza virus, major infectious hepatitis virus, canine parainfluenza virus, or other viral diseases
•  Tumor diseases: mainly targeting cauliflower-like tumors in the genitals, oral cavity, and other parts caused by the virus.

Technical Parameter

1. Usage and Dosage

• Recombinant canine interferon A: Dissolve each vial with 1ml of water for injection and inject subcutaneously. The recommended dosage is 400000 U/kg, once a day for 5 days as a course of treatment, or as directed by a doctor
• When symptoms such as canine distemper are more obvious in the eyes and nose, 1ml of injection water can be used to dissolve and dilute each bottle, and then eye drops and nose drops can be applied 3-5 times a day. At the same time, the method of injecting interferon remains the same

2. Storage

• 2-8 ℃ refrigerated storage